← All organizations

Durect

For profitWebsite ↗

Also known as: Durect | DURECT

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Oct 31, 2020

Timeline

1990s

Jun 1, 1998
Durect— Founded

2020s

Feb 1, 2021
levobupivacaine— Marketing Organization

Drugs by trial phase (5 distinct, 16 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

levobupivacaine

Recent trials (20)

NCT04563026Lead sponsorPhase 2Oct 31, 2020
NCT04447404Lead sponsorPhase 2Sep 21, 2020
NCT03837743CollaboratorPhase 2Feb 21, 2019
NCT03432260Lead sponsorPhase 2Apr 18, 2018
NCT03394781Lead sponsorPhase 2Jan 22, 2018
NCT02704390CollaboratorPhase 3Jan 1, 2016
NCT02574520Study directorPhase 3Nov 1, 2015
NCT02574520Lead sponsorPhase 3Nov 1, 2015
NCT02450890CollaboratorPhase 3Jun 1, 2015
NCT01096966CollaboratorPhase 2Mar 1, 2010
NCT01052012Study directorPhase 3Dec 1, 2009
NCT01052012Lead sponsorPhase 3Dec 1, 2009
NCT00993226Lead sponsorPhase 2May 1, 2009
NCT00993798Lead sponsorPhase 2Apr 1, 2009
NCT00818363Lead sponsorPhase 2Dec 1, 2008

Details

Founded: Cupertino, California, US Jun 1, 1998
Last known activity: Oct 31, 2020